257
Views
12
CrossRef citations to date
0
Altmetric
Original Articles

People Who Inject Drugs and Have Mood Disorders—A Brief Assessment of Health Risk Behaviors

, , &

References

  • Akselrod, H., Grau, L. E., Barbour, R., & Heimer, R. (2014). Seroprevalence of HIV, hepatitis B virus, and HCV among injection drug users in connecticut: Understanding infection and coinfection risks in a nonurban population. American Journal of Public Health, 104(9), 1713–1721. doi:10.2105/AJPH.2013.301357
  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed.). Washington, DC: Author.
  • Belani, H., Chorba, T., Fletcher, F., Hennessey, K., Kroeger, K., Lanksky, M., Leichliter, J. … Wynn, B. (2012). Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: Summary guidance from CDC and the U.S. Department of Health and Human Services. Morbidity and Mortality Weekly Report, 61(rr05), 1–40.
  • Brady, J. E., Friedman, S. R., Cooper, H. L., Flom, P. L., Tempalski, B., & Gostnell, K. (2008). Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. Journal of Urban Health, 85(3), 323–351. doi:10.1007/s11524-007-9248-5
  • Buckingham, E., Schrage, E., & Cournos, F. (2013). Why the treatment of mental disorders is an important component of HIV prevention among people who inject drugs. Advances in Preventive Medicine, 2013, 690386. doi:10.1155/2013/690386
  • Center for HIV Surveillance and Epidemiology, Infectious Disease and Environmental Health Administration, & Maryland Department of Health and Mental Hygiene. (2012). Baltimore city HIV/AIDS epidemiological profile, fourth quarter 2011 - data reported through December 21, 2011. Retrieved from http://phpa.dhmh.maryland.gov/OIDEOR/CHSE/Shared%20Documents/Baltimore_City_HIV_AIDS_Epidemiological_Profile_12_2010.pdf
  • Centers for Disease Control and Prevention. (2013). HIV surveillance report, 2011 (Vol. 23). Retrieved from http://www.cdc.gov/hiv/topics/surveillance/resources/reports/
  • Cluss, P. A., Marcus, S. C., Kelleher, K. J., Thase, M. E., Arvay, L. A., & Kupfer, D. J. (1999). Diagnostic certainty of a voluntary bipolar disorder case registry. Journal of Affective Disorders, 52(1–3), 93–99.
  • Darke, S., & Hall, W. (2003). Heroin overdose: research and evidence-based intervention. Journal of Urban Health, 80(2), 189–200. doi:10.1093/jurban/jtg022
  • Degenhardt, L., Hall, W., & Warner-Smith, M. (2006). Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS. Sexually Transmitted Infections, 82(Suppl 3), iii56–ii63. doi:10.1136/sti.2005.019273
  • German, D., & Latkin, C. A. (2012). Boredom, depressive symptoms, and HIV risk behaviors among urban injection drug users. AIDS and Behavior, 16(8), 2244–2250. doi:10.1007/s10461-012-0247-5
  • Gu, J., Lau, J. T., Chen, H., Chen, X., Liu, C., & Liu, J. (2010). Mental health and interpersonal factors associated with HIV-related risk behaviors among non-institutionalized female injection drug users who are also sex workers in China. Women Health, 50(1), 20–36. doi:10.1080/03630241003601137
  • Havens, J. R., Sherman, S. G., Sapun, M., & Strathdee, S. A. (2006). Prevalence and correlates of suicidal ideation among young injection vs. noninjection drug users. Substance Use & Misuse, 41(2), 245–254. doi:10.1080/10826080500391811
  • Jin, H., Atkinson, J. H., Duarte, N. A., Yu, X., Shi, C., Riggs, P. K., … HNRC China Collaboration Group (2013). Risks and predictors of current suicidality in HIV-infected heroin users in treatment in Yunnan, China: a controlled study. Journal of Acquired Immune Deficiency Syndromes, 62(3), 311–316. doi:10.1097/QAI.0b013e31827ce513
  • Johnson, M. E., Yep, M. J., Brems, C., Theno, S. A., & Fisher, D. G. (2002). Relationship among gender, depression, and needle sharing in a sample of injection drug users. Psychology of Addictive Behaviors, 16(4), 338–341.
  • Kessler, R. C., Akiskal, H. S., Ames, M., Birnbaum, H., Greenberg, P., Hirschfeld, R. M., … Wang, P. S. (2006). Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. The American Journal of Psychiatry, 163(9), 1561–1568. doi:10.1176/appi.ajp.163.9.1561
  • Kessler, R. C., Chiu, W. T., Demler, O., Merikangas, K. R., & Walters, E. E. (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 617–627. doi:10.1001/archpsyc.62.6.617
  • Latkin, C. (n.d.). A network & dyad HIV prevention intervention for IDUs. Retrieved from http://clinicaltrials.gov/show/NCT00218335
  • Lemstra, M., Rogers, M., Thompson, A., Moraros, J., & Buckingham, R. (2011). Risk indicators of depressive symptomatology among injection drug users and increased HIV risk behaviour. The Canadian Journal of Psychiatry, 56(6), 358–366.
  • Mackesy-Amiti, M. E., Donenberg, G. R., & Ouellet, L. J. (2012). Prevalence of psychiatric disorders among young injection drug users. Drug and Alcohol Dependence, 124(1–2), 70–78. doi:10.1016/j.drugalcdep.2011.12.012
  • Mackesy-Amiti, M. E., Donenberg, G. R., & Ouellet, L. J. (2014). Psychiatric correlates of injection risk behavior among young people who inject drugs. Psychology of Addictive Behaviors, 28(4), 1089–1095. doi:10.1037/a0036390
  • Mandell, W., Kim, J., Latkin, C., & Suh, T. (1999). Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. The American Journal of Drug and Alcohol Abuse, 25(1), 117–127.
  • Maremmani, I., Maremmani, A. G., Rugani, F., Rovai, L., Pacini, M., Bacciardi, S., … Akiskal, H. S. (2012). Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry. Annals of General Psychiatry, 11(1), 23. doi:10.1186/1744-859X-11-23
  • Maremmani, I., Pacini, M., Perugi, G., Deltito, J., & Akiskal, H. (2008). Cocaine abuse and the bipolar spectrum in 1090 heroin addicts: clinical observations and a proposed pathophysiologic model. Journal of Affective Disorders, 106(1–2), 55–61. doi:10.1016/j.jad.2007.03.015
  • Maremmani, I., Pani, P. P., Canoniero, S., S., Pacini, M., Perugi, G., Rihmer, Z., & Akiskal, H. S. (2007). Is the bipolar spectrum the psychopathological substrate of suicidality in heroin addicts? Psychopathology, 40(5), 269–277. doi:10.1159/000104742
  • Maremmani, I., Perugi, G., Pacini, M., & Akiskal, H. S. (2006). Toward a unitary perspective on the bipolar spectrum and substance abuse: Opiate addiction as a paradigm. Journal of Affective Disorders, 93(1–3), 1–12. doi:10.1016/j.jad.2006.02.022
  • Meade, C. S., Fitzmaurice, G. M., Sanchez, A. K., Griffin, M. L., McDonald, L. J., & Weiss, R. D. (2011). The relationship of manic episodes and drug abuse to sexual risk behavior in patients with co-occurring bipolar and substance use disorders: a 15-month prospective analysis. AIDS and Behavior, 15(8), 1829–1833. doi:10.1007/s10461-010-9814-9
  • Meade, C. S., Graff, F. S., Griffin, M. L., & Weiss, R. D. (2008). HIV risk behavior among patients with co-occurring bipolar and substance use disorders: associations with mania and drug abuse. Drug and Alcohol Dependence, 92(1–3), 296–300. doi:10.1016/j.drugalcdep.2007.07.013
  • Meade, C. S., & Sikkema, K. J. (2005). HIV risk behavior among adults with severe mental illness: a systematic review. Clinical Psychology Review, 25(4), 433–457. doi:10.1016/j.cpr.2005.02.001
  • Meade, C. S., & Sikkema, K. J. (2007). Psychiatric and psychosocial correlates of sexual risk behavior among adults with severe mental illness. Community Mental Health Journal, 43(2), 153–169. doi:10.1007/s10597-006-9071-6
  • National Institue on Drug Abuse. (2008). Comorbidity: Addiction and other mental illnesses. NIDA Research Report Series. Retrieved from http://www.drugabuse.gov/sites/default/files/rrcomorbidity.pdf
  • Pabayo, R., Alcantara, C., Kawachi, I., Wood, E., & Kerr, T. (2013). The role of depression and social support in non-fatal drug overdose among a cohort of injection drug users in a Canadian setting. Drug and Alcohol Dependence, 132(3), 603–609. doi:10.1016/j.drugalcdep.2013.04.007
  • Perdue, T., Hagan, H., Thiede, H., & Valleroy, L. (2003). Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men. AIDS Education and Prevention, 15(1), 81–92.
  • Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401.
  • Rosenberg, S. D., Goodman, L. A., Osher, F. C., Swartz, M. S., Essock, S. M., Butterfield, M. I., … Salyers, M. P. (2001). Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. American Journal of Public Health, 91(1), 31–37.
  • Santibanez, S. S., Garfein, R. S., Swartzendruber, A., Purcell, D. W., Paxton, L. A., & Greenberg, A. E. (2006). Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States. Journal of Urban Health, 83(1), 86–100. doi:10.1007/s11524-005-9009-2
  • Stein, M. D., Solomon, D. A., Herman, D. S., Anderson, B. J., & Miller, I. (2003). Depression severity and drug injection HIV risk behaviors. The American Journal of Psychiatry, 160(9), 1659–1662.
  • Substance Abuse and Mental Health Services Administration. (2013, August 16). National Survey on Drug Use and Health, 2012. Retrieved from http://www.icpsr.umich.edu/icpsrweb/SAMHDA/studies/34481
  • Tobin, K. E., Kuramoto, S. J., Davey-Rothwell, M. A., & Latkin, C. A. (2011). The STEP into Action study: a peer-based, personal risk network-focused HIV prevention intervention with injection drug users in Baltimore, Maryland. Addiction, 106(2), 366–375. doi:10.1111/j.1360-0443.2010.03146.x

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.